NMDA receptor stimulation in the absence of extracellular Ca2+ potentiates Ca2+ influx-dependent cell death system.
The meaning of Ca2+ influx in the time course of glutamate stimulation of neuronal cells was addressed. We demonstrated that Ca2+ influx did not work straightforward in the determination of the fate of neuronal cells. There appears to be a critical period for Ca2+ influx to work efficiently in glutamate-induced neuronal cell death. When Ca2+ influx for 5 min from the beginning of glutamate stimulation was allowed in the whole stimulation period for 15 min, potent neuronal cell death could not be attained. On the other hand, when neuronal cells had been pre-treated with glutamate or NMDA for 5-10 min in the absence of extracellular Ca2+ following Ca2+ influx for 5 min fully induced neuronal cell death. APV inhibited this pre-treatment effect. It appears that the pre-treatment of neuronal cells with glutamate or NMDA in the absence of extracellular Ca2+ promotes the Ca2+ influx-dependent process executing cell death. The pre-treatment itself did not change the pattern of intracellular Ca2+ elevation by the activation of NMDA receptors. These results imply that glutamate activation of NMDA receptors consists of two different categories of pathways relating to neuronal cell death, i.e., Ca2+ influx independent and dependent, and that the former facilitates the latter to drive neuronal cells to death. This study clarified a mechanism by which glutamate quickly determines cell fate.
Kato
Kohtaro
K
Department of Cellular Physiological Chemistry, Graduate School, Tokyo Medical and Dental University, Yushima 1-5-45, Bunkyo-ku, Tokyo-113-8549, Japan. katocell@tmd.ac.jp
Murota
Sei-itsu
SI
D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000378:metabolism* / Q000502:physiology; D016923:Cell Death / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D002540:Cerebral Cortex / Q000378:metabolism; D004357:Drug Synergism; D045604:Extracellular Fluid / Q000378:metabolism*; D005260:Female; D018698:Glutamic Acid / Q000494:pharmacology; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors / Q000378:metabolism*
D016194:Receptors, N-Methyl-D-Aspartate; D018698:Glutamic Acid; D015763:2-Amino-5-phosphonovalerate; D002118:Calcium